A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers

A Study to Evaluate the Effect of Moderate or Severe Hepatic Impairment on the Pharmacokinetics (PK) of Inavolisib

NCT07144111 ·Status: RECRUITING ·Phase: PHASE1

A Study of Safety, Tolerability, and Pharmacokinetics of Multiple-Dose CC-90001 in Japanese and Caucasian Healthy Subjects

NCT03958864 ·Status: COMPLETED ·Phase: PHASE1

Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-0669 in Healthy Adult Participants

NCT07050511 ·Status: COMPLETED ·Phase: PHASE1

A Safety, Tolerability and Pharmacokinetic Study of a Single Dose of CMX157 in Healthy Volunteers

NCT01080820 ·Status: COMPLETED ·Phase: PHASE1

The Tolerability and Pharmacokinetics Clinical Trial of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers

NCT03180333 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers

NCT07110441 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacokinetics of CMX001 in Impaired Hepatic Function and Healthy Subjects

NCT05391724 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess S-217622 in Participants With Mild and Moderate Hepatic Impairment and Healthy Control Participants

NCT05409911 ·Status: COMPLETED ·Phase: PHASE1

First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics

NCT07169318 ·Status: RECRUITING ·Phase: PHASE1

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Maribavir Administered in Healthy Japanese Participants Compared With Matched, Healthy, Non-Hispanic, Caucasian Participants and to Assess Dose-Proportionality of 3 Doses of Maribavir in Japanese Participants

NCT04497883 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Pharmacokinetics of Single Oral Doses of Ozanimod in Healthy Adult Chinese Subjects

NCT04211558 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacokinetics of Zanubrutinib (BGB-3111) in Healthy Subjects and Those With Impaired Liver Function

NCT03465059 ·Status: COMPLETED ·Phase: PHASE1

CP-690,550 Pharmacokinetics In Healthy Chinese Subjects

NCT01101919 ·Status: COMPLETED ·Phase: PHASE1

INC280 in Healthy Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function

NCT02474537 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment

NCT03289234 ·Status: COMPLETED ·Phase: PHASE1

A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses in Participants With Chronic Hepatitis B

NCT03439488 ·Status: COMPLETED ·Phase: PHASE1

A Multi-cohort Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers

NCT04539340 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19

NCT04582318 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Clinical Study of Ulonivirine (MK-8507) With Atorvastatin and Metformin in Healthy Adults (MK-8507-018)

NCT07530289 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacokinetic Study to Assess the Influence of Simultaneous CYP3A4 and P-glycoprotein Inhibition on E7080 Pharmacokinetics Following Single Dose Oral Administration of 5 mg E7080 to Healthy Volunteers

NCT02198170 ·Status: COMPLETED ·Phase: PHASE1

Ulonivirine (MK-8507) in Participants With Mild or Moderate Hepatic Impairment (MK-8507-014)

NCT05093972 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Pharmacokinetics and Safety of the Co-administration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Healthy Chinese Subjects

NCT02534870 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7079901 and the Combination of RO7079901 With Meropenem in Adult Healthy Volunteers

NCT02972255 ·Status: COMPLETED ·Phase: PHASE1

A Study of Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 Infection

NCT05697055 ·Status: UNKNOWN ·Phase: PHASE4

Hepatic Impairment and Renal Impairment Study of SIM0417 Combined With Ritonavir

NCT05731804 ·Status: UNKNOWN ·Phase: PHASE1